Ariadne Expands Presence in South-East Asia
Genomax Technologies to Distribute Ariadne Software in the Region
Advertisement
Ariadne genomics, Inc. announced that is has signed a distributor agreement with Genomax Technologies Pte. Ltd. (Singapore) to represent Ariadne products in South-East Asia. Genomax will be distributing and supporting Ariadne pathway analysis software to life scientists in Singapore, Malaysia and Thailand.
"We are glad that Genomax has joined Ariadne sales team", said John Clouston, Sales Manager at Ariadne. "Genomax is a key supplier for the life science research in South-East Asia, specifically focused on the areas of genomics, proteomics, molecular and cell biology, and we expect this relationship to be long and prosperous".
Most read news
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Hidden RNA repair mechanism discovered in humans - Function of a previously uncharacterized human protein elucidated
Experience leads to the growth of new brain cells - A new study examines how individuality develops
Enzo rejects Roche settlement offer - Roche responds with lawsuit
Cold Spring Biotech Corp. to Distribute Strand Genomics' avadis in Taiwan
Syngenta files suit to enforce biotechnology patents
MediGene Receives New US Patent for Cancer-Killing Viruses - Patent protects herpes simplex viruses (HSV) genetically modified to activate the immune system against tumor cells
YM Bioscience reports Phase II data for nimotuzumab in metastatic colorectal cancer - Overall Survival And Disease Control Outcomes, Coupled With Low Toxicity, Support The Continued Development Of The EGFR Antibody In Patients With Colorectal Cancer
SYGNIS completes acquisition of TGR Biosciences
Chemist developed a green catalyst for pharmaceutical and industrial chemistry - Catalyst based on a substance that comes from plant waste
Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics - Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
Celera Genomics Presents Preclinical Data on its Human Histone Deacetylase (HDAC) Inhibitor